Choroidal Structural Changes in Sympathetic Ophthalmia on Swept-Source Optical Coherence Tomography. 2021

Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.

Purpose: To analyze choroidal angioarchitecture in sympathetic ophthalmia (SO) using swept-source optical coherence tomography (SS-OCT) images.Methods: Case-control study of six patients with SO. Qualitative changes and quantitative parameters, including choroidal thickness (CT) and choroidal vascularity index (CVI), were analyzed.Results: Qualitative findings in the acute phase of SO on SS-OCT included retinal serous detachment with hyperreflective septa, choroidal folds, alterations in angioarchitecture with loss of vascular lacunae, and Dalen-Fuchs nodules. There was significantly higher CT in SO (284.05 ± 24.12 µm) compared to healthy controls (229.57 ± 46.67 µm, p = 0.04) and also increased CVI in SO (62.06 ± 2.07% vs 56.79 ± 3.15%, p = 0.006).Conclusions: CVI was significantly increased in SO, representing a novel noninvasive biomarker of disease activity. SS-OCT provides a useful qualitative and quantitative parameter, which can be potentially explored in the diagnosis and monitoring of patients with SO.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009879 Ophthalmia, Sympathetic Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye. Uveitis, Sympathetic,Ophthalmias, Sympathetic,Sympathetic Ophthalmia,Sympathetic Ophthalmias,Sympathetic Uveitides,Sympathetic Uveitis,Uveitides, Sympathetic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002829 Choroid The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA. Choriocapillaris,Haller Layer,Haller's Layer,Sattler Layer,Sattler's Layer,Choroids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
December 2018, Retina (Philadelphia, Pa.),
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
August 2016, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
July 2018, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
January 2015, American journal of ophthalmology,
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
February 2018, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
March 2021, Retina (Philadelphia, Pa.),
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
January 2019, The British journal of ophthalmology,
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
June 2024, Lasers in medical science,
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
June 2021, Retina (Philadelphia, Pa.),
Rupesh Agrawal, and Mukesh Jain, and Rehana Khan, and Durgasri Jaisankar, and Wei Xin, and Jianbin Ding, and Ilaria Testi, and Rajiv Raman, and Jyotirmay Biswas
January 2020, Journal of ophthalmology,
Copied contents to your clipboard!